Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
- 1 September 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (9) , 1138-1145
- https://doi.org/10.1007/bf01254246
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Breast cancerCancer, 1995
- Breast cancer trends Incidence, mortality, and survivalCancer, 1994
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- The positive predictive value of mammography.American Journal of Roentgenology, 1992
- Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1991
- Randomized study of mammography screening — preliminary report on mortality in the stockholm trialBreast Cancer Research and Treatment, 1991
- Esophageal motility: assessment with synchronous video tape fluoroscopy and manometry.Radiology, 1989
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988